Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Tavecchio

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
International Clinical Psychopharmacology|October 2, 2023
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?Silvia Mariel Ferrucci, Simona Tavecchio, Gregorio Nicolini, et al.
Therapeutic Advances in Allergy and Rhinology|June 9, 2025
Effectiveness of Dupilumab Treatment in Patients With Type 2 Inflammation: A Real-Life Integrated ExperienceSara Torretta, Gioia Piatti, Chiara Catalano, et al.
Dermatologic Therapy|March 4, 2020
Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adultsCataldo Patruno, Luca Stingeni, Katharina Hansel, et al.
Journal of the American Academy of Dermatology|February 15, 2019
Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter studyFederica Guicciardi, Laura Atzori, Angelo Valerio Marzano, et al.
Clinical and Experimental Dermatology|June 11, 2024
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patientsSilvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, et al.
Clinical and Translational Allergy|September 25, 2023
A concept for integrated care pathways for atopic dermatitis-A GA<sup>2</sup> LEN ADCARE initiativeTorsten Zuberbier, Amir Abdul Latiff, Xenofon Aggelidis, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
International Clinical Psychopharmacology|October 2, 2023
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?Silvia Mariel Ferrucci, Simona Tavecchio, Gregorio Nicolini, et al.
Therapeutic Advances in Allergy and Rhinology|June 9, 2025
Effectiveness of Dupilumab Treatment in Patients With Type 2 Inflammation: A Real-Life Integrated ExperienceSara Torretta, Gioia Piatti, Chiara Catalano, et al.
Dermatologic Therapy|March 4, 2020
Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adultsCataldo Patruno, Luca Stingeni, Katharina Hansel, et al.
Journal of the American Academy of Dermatology|February 15, 2019
Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter studyFederica Guicciardi, Laura Atzori, Angelo Valerio Marzano, et al.
Clinical and Experimental Dermatology|June 11, 2024
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patientsSilvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, et al.
Clinical and Translational Allergy|September 25, 2023
A concept for integrated care pathways for atopic dermatitis-A GA<sup>2</sup> LEN ADCARE initiativeTorsten Zuberbier, Amir Abdul Latiff, Xenofon Aggelidis, et al.
Pageof 3